Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Neuroendocrinology|July 1, 1984
Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxoneG B Melis, A M Paoletti, M Gambacciani, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1986
Evidence of specific benzodiazepine binding to myometrial membrane preparations from human pregnant uterusP Fioretti, G B Melis, M Gambacciani, et al.
Obstetrics and Gynecology|March 1, 1994
Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolismM Gambacciani, A Spinetti, F Taponeco, et al.
Climacteric : the Journal of the International Menopause Society|January 3, 2019
Vaginal atrophy across the menopausal age: results from the ANGEL studyA Cagnacci, A Xholli, M Sclauzero, et al.
American Journal of Obstetrics and Gynecology|September 1, 1995
Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluationM Gambacciani, A Spinetti, R Gallo, et al.
Climacteric : the Journal of the International Menopause Society|October 29, 2010
Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective studyM Gambacciani, G Rosano, B Cappagli, et al.
Neuroendocrinology|February 1, 1989
Pulsatile gonadotropin-releasing hormone release from the human mediobasal hypothalamus in vitro: opiate receptor-mediated suppressionD D Rasmussen, M Gambacciani, W Swartz, et al.
Maturitas|December 1, 1992
Effects of continuous and cyclic nasal calcitonin administration in ovariectomized womenP Fioretti, M Gambacciani, F Taponeco, et al.
Climacteric : the Journal of the International Menopause Society|April 29, 2017
Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?N Biglia, A Cagnacci, M Gambacciani, et al.
Neuroendocrinology|February 1, 1988
Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal womenG B Melis, A Cagnacci, M Gambacciani, et al.
Pageof 10